Cosmos Health has secured $300 million in senior secured convertible notes to establish an Ethereum reserve strategy focused on yield generation and enhanced shareholder value. This corporate treasury initiative is directly influenced by the regulatory framework of the recently enacted GENIUS Act.
The funding will support ETH accumulation and advanced yield-based treasury management, with plans to explore staking and lending mechanisms for revenue generation. The GENIUS Act’s recognition of cryptocurrency assets as regulated stores of value has accelerated institutional Ethereum adoption among corporations.
This strategic move aligns with a growing trend of businesses leveraging Ethereum’s programmable features for treasury operations. Cosmos Health aims to optimize returns while maintaining portfolio diversity through Ethereum-based financial instruments.
The development underscores increased corporate confidence in blockchain-based assets for capital allocation, signaling broader acceptance of digital assets under evolving regulatory frameworks.